In the authors' words
“Hormone replacement therapy did not increase muscle performance, improve balance or reduce falls over a year in middle-aged women.”
What was measured
- Muscle strength No difference found
- Balance and falls No difference found
About the study
- Type
- Randomised trial
- Who took part
- Postmenopausal, other condition
- How many
- 116
- How long
- 48 weeks
- Exercise
- Exercise with hormone therapy
- Cited
- 56 times, per Europe PMC
- PubMed ID
- 8976803
How to read this. Each line is one study, summarised in plain language from its PubMed abstract, with the authors' own sentence underneath on the study page. A count of studies is not a verdict: trials differ in size, length and quality, and a result in one group of women may not hold in another. Nothing here is medical advice.
Summaries are generated, then checked by machine against the abstract they came from; any summary that could not be matched word for word was left out. Our clinical lead is reviewing the summaries topic by topic, and this note will change when that is done. Corpus last refreshed 2026-11-03. Spotted a mistake? Tell us and we will fix the summary or remove the study.
Similar studies
- Women aged 50 to 57 did 12 months of high-impact exercise with or without hormone therapy; combined exercise plus hormones increased knee strength, jump height and muscle area more than either alone.
- Postmenopausal women aged 50 to 57 did a year of high-impact lower-limb training with or without hormone therapy, with jump height and running speed improving in hormone and combined groups.
- Postmenopausal women aged 49 to 55 took hormone therapy or placebo, each with or without exercise, and researchers found exercise improved bone density mainly in the placebo group, with no added effect when combined with estrogen.
- Postmenopausal women aged 40 to 66 did a 1 year supervised resistance training program and gained lean mass and strength, with fat loss seen mainly in those also on hormone therapy.